Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-005257

GW PHARMACEUTICALS PLC · GWPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Scott M. Giacobello
Officer — Chief Financial Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2Feb 26, 2019M10,404$0.0013A15,768D
Ordinary SharesF3,F4Feb 26, 2019S1,584$12.42D14,184D
Ordinary SharesF3,F4Feb 26, 2019S3,600$12.46D10,584D
Ordinary SharesF3,F4Feb 26, 2019S48$12.38D10,536D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionsF2$0.0013Feb 26, 2019M10,404DFeb 26, 2019Mar 15, 2020Ordinary Shares10,4043D

Explanation of responses